FMP
Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Receives $17 Price Target from Chardan Capital
On October 7, 2025, Chardan Capital set a price target of $17 for Lexeo Therapeutics, Inc. (NASDAQ:LXEO). At the time, the stock was trading at $8.25, suggesting a potential increase of about 94%. Lexeo is a clinical-stage genetic medicine company focused on developing treatments for rare diseases. Its competitors include other biotech firms working on genetic therapies. Lexeo has made significant progress with the FDA regarding an Accelerated Approval pathway for its treatment, LX2006, targeti...
Read MoreTrilogy Metals, Inc. (AMEX:TMQ) Sees Significant Attention with Ambler Road Project
Trilogy Metals, Inc. (AMEX:TMQ) is a Canadian mining company that has recently gained significant attention. The company focuses on developing mineral proj...
Director's Purchase and Company Overview of UMH Properties, Inc. (NYSE:UMH)
On October 7, 2025, Clark Todd J., a director at UMH Properties, Inc. (NYSE:UMH), purchased 527.23 shares at $14.23 each. This acquisition increased his to...
ASML Holding N.V. (NASDAQ:ASML) Maintains Strong Position in Semiconductor Industry
ASML Holding N.V. (NASDAQ:ASML) is a key player in the semiconductor industry, known for its advanced lithography machines used in chip manufacturing. On O...
Earnings Calendar
Earnings Call Transcripts
Stock Gainer
Stock Losers
Most Searched Stocks
Highest Volume
Market News
Market Movements: Analyzing Top Losers and Their Impact
In recent market movements, several companies have experienced significant price changes, impacting their market positions. Here's a consolidated analysis ...
Constellation Brands Shares Rise 2% As Earnings Beat Expectations
Shares of Constellation Brands Inc. (NYSE: STZ) climbed more than 2% intra-day on Tuesday after the company reported quarterly earnings that topped Wall St...
McCormick Reports Strong Quarter With Volume-Led Growth, Reaffirms Sales Outlook
McCormick & Company, Incorporated (NYSE: MKC) reported third-quarter results that beat analyst expectations, marking its fifth consecutive quarter of volum...
HSBC Initiates Alphabet Coverage With Buy Rating And $285 Price Target
HSBC initiated coverage on Alphabet Inc. (NASDAQ: GOOGL) with a Buy rating and a price target of $285.00, citing confidence in the company’s full-stack art...
Needham Downgrades TrueCar To Hold, Stock Drops
Needham downgraded TrueCar Inc. (NASDAQ: TRUE) from Buy to Hold, sending shares down more than 14% intra-day on Tuesday. The firm said its bullish thesi...
Seaport Global Upgrades Netflix To Buy, Shares Rise 2%
Seaport Global Securities upgraded Netflix Inc. (NASDAQ: NFLX) from Neutral to Buy, assigning a new price target of $1,385.00. Shares rose more than 2% int...
Piper Sandler Trims ExxonMobil Price Target To $141, Keeps Overweight Rating
Piper Sandler reduced its price target on ExxonMobil (NYSE: XOM) to $141.00 from $145.00 while maintaining an Overweight rating. The firm said ExxonMobi...
T-Mobile US, Inc. (NASDAQ:TMUS): A Strong Contender in the Telecom Industry
T-Mobile US, Inc. (NASDAQ:TMUS) is a leading telecom provider in the United States, known for its robust network and customer-centric services. The company...
McCormick & Company, Inc. (NYSE:MKC) Surpasses Earnings Estimates
McCormick & Company, Inc. (NYSE:MKC) is a global leader in the flavor industry, known for its premium spices and seasonings. The company has a strong marke...
Levi Strauss & Co. (NYSE: LEVI) Quarterly Earnings Overview
Levi Strauss & Co. (NYSE: LEVI) is a well-known American clothing company, famous for its iconic denim jeans. The company operates globally, selling its pr...
JPMorgan Chase & Co. (NYSE:JPM) Earnings Preview and Financial Analysis
JPMorgan Chase & Co. (NYSE:JPM) is a leading global financial institution, known for its comprehensive range of services and significant market presence. A...
AngioDynamics, Inc. (NASDAQ: ANGO) Surpasses Q1 Fiscal 2026 Earnings Expectations
AngioDynamics, Inc. (NASDAQ: ANGO) is a key player in the medical technology industry, focusing on enhancing blood flow in the vascular system and expandin...
Netflix (NASDAQ:NFLX) Stock Price Target Set by Seaport Global
Netflix (NASDAQ:NFLX) is a leading streaming service provider known for its vast library of movies, TV shows, and original content. The company has faced c...
Netflix (NASDAQ:NFLX) Stock Upgrade by Seaport Global
Netflix (NASDAQ:NFLX) is a leading streaming service provider known for its vast library of movies, TV shows, and original content. The company has been a ...